Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect?

Enliven Therapeutics, Inc. (ELVN) closed the last trading session at $22.07, gaining 3.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $41.38 indicates an 87.5% upside potential.The average comprises eight short-term price targets ranging from a low of $33.00 to a high of $52.00, with a standard deviation of $6.52. While the lowest estimate indicates an increase of 49.5% from th ...